Targeting HIF-1 and mTOR expression in hypoxic and normoxic liver cancer cells; towards optimal combination therapy for DEB-TACE.

Activity: Talk or presentation typesOral presentation

Period19 Sep 201021 Sep 2010
Event titleCancer and metabolism: Pathways to the Future
Event typeConference
LocationEdinburgh, United Kingdom
Degree of RecognitionInternational